Three Biotech Stocks That Have Triggered Alerts: ABEO, IPCI, And VBIO

Three stocks that are trading sharply higher in early Tuesday trading include Abeona (ABEO), Intellipharmaceutics (IPCI) and Vitality Biopharma (VBIO). Trades Ideas provided real-time price alerts on these closely-watched CNA Finance stocks. Abeona ABEO is trading higher by 4.7%, breaching the $5.00 level for the first time in two weeks. No specific news for ABEO … Read more

Abeona Therapeutics (ABEO) Stock: Cutting Edge And A $120 Price Target

Abeona Therapeutics Inc (NASDAQ: ABEO) Okay, so I’m jumping on the bandwagon of a scathing rebuttal that was posted on a blog site by “World’s Greatest.” It refutes, point by point, the hit piece that was recently done on ABEO by an admitted and masked short seller. But, even though my headline may appear boisterous, ABEO … Read more

Raging Bull Portfolio: Abeona (ABEO) and Intellipharmaceutics (IPCI)

Abeona Therapeutics Inc (NASDAQ: ABEO) | IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) Part of my routine in preparation for the next week’s trading market is to identify stocks that have no apparent reason to have been beaten down to levels that make little to no sense. I identify two a week and then put together my … Read more

Abeona Therapeutics (ABEO) Stock: Banks $42 Million Bucks, Eliminates Financial Headwinds

Abeona Therapeutics Inc (NASDAQ: ABEO) Abeona Therapeutics announced on Thursday the pricing of its public offering of common shares, agreeing to sell six million shares at $7.00 per share and granting the underwriters an additional 30-day option to purchase an additional 900K shares at the same price. Total expected proceeds from the deal are estimated … Read more

Abeona Therapeutics (ABEO) Stock: Yet Another Reason To Be Bullish

Abeona Therapeutics Inc (NASDAQ: ABEO) Abeona Therapeutics is a stock that has many divided. However, today, I’d be willing to bet that many of the bears are starting to turn into bulls. That’s because the company made a key announcement with incredibly positive news today. Below, we’ll talk about what we learned in the announcement, … Read more

Abeona Therapeutics (ABEO) Stock: Gaining Big On Positive ABO-102 Data

Abeona Therapeutics Inc (NASDAQ: ABEO) Abeona Therapeutics is having an incredibly strong day in the market today, and for good reason. The company released an update surrounding ABO-102. Today, we’ll talk about the release, how the stock reacted to the news, and what we can expect to see from ABEO moving forward. Trade smarter and … Read more

Abeona Therapeutics (ABEO) Stock: Gaining Big On Orphan Drug Designation In Europe

Abeona Therapeutics Inc (NASDAQ: ABEO) Abeona Therapeutics is having an incredible day in the market today, and for good reason. In an early morning press release, the company informed investors that it has received the Orphan Drug Designation in the EU for a key clinical stage treatment. Today, we’ll talk about the designation, how the … Read more

Abeona Therapeutics (ABEO) Stock: Is The Company Doing Everything Right?

Abeona Therapeutics Inc (NASDAQ: ABEO) Abeona Therapeutics is one of those companies that is set enviably into a unique niche of science that, if they prove to be successful, should meet little competitive headwind. As a gene therapy company, ABEO is relatively insulated from the speed at which competitors can enter the market.  With new … Read more